Use of Hypothermically Stored Amniotic Membrane on Diabetic Foot Ulcers



Use of Hypothermically Stored Amniotic Membrane on Diabetic Foot Ulcers: A Multicentre Retrospective Case Series

Summary: Multicenter retrospective (n=50 DFUs) evaluated hypothermically stored amniotic membrane (HSAM) + SOC. 78% complete closure by week 12 (median 55 days); >60% area reduction in 96%; mean 5.5 applications (interval 7.5 days). From presentation to baseline: -68.3% area. Positive outcomes suggest HSAM accelerates healing, reduces financial burden/QoL impact in DFUs.

Key Highlights:

  • Closure: 78% week 12; median 55 days.
  • Reduction: >60% area in 96%; -68.3% pre-baseline.
  • Applications: Mean 5.5; 7.5-day interval.
  • Patients: 68% male, mean age 66.7, area 3.5 cm².
  • Authors: Not specified in summary.

Read case series

Keywords: HSAM, DFU, amniotic membrane, retrospective, healing rates